Author’s reply: can budesonide form be alterative treatment for ulcerative proctosigmoiditis?
Crossref DOI link: https://doi.org/10.1007/s00535-018-1462-2
Published Online: 2018-04-03
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Naganuma, Makoto
Text and Data Mining valid from 2018-04-03
Article History
First Online: 3 April 2018
Compliance with ethical standards
:
: Makoto Naganuma received research grants from EA Pharma Co., Ltd. and Zeria Pharmaceutical Co., Ltd., outside the submitted manuscript.